美国生物类似药的使用与医疗保险支付策略分析——基于Pfizer vs. Johnson案的思考 *
董心月,蒋蓉,里扎·阿德列提别克,邵蓉
The Clinical Use and Insurance of Biosimilars in the US ——Taking the Pfizer vs. Johnson Lawsuit as an Example
DONG Xin-yue,JIANG Rong,LIZHA Adelietibieke,SHAO Rong
中国生物工程杂志
.
2019, (12): 95
-102
.
DOI: 10.13523/j.cb.20191212
